5 months ago
BHVN
AnalystsChristopher RaymondChristopher Raymond's Stock Forecasts
AnalystsChristopher Raymond
Analyst Ranking
Top 12%
#531 out of 4552 analysts
Average Return
+9.59%
Win Rate
56%42 out of 75
Risk vs Reward
Poor
Good
Christopher Raymond's 5 best and worst ratings
| Name / Ticker | Gain/Loss | Entry Price | Exit Price | Period | Rating |
|---|---|---|---|---|---|
Alx Oncology Holdings IncALXO | +217.79% | $5.06 | $16.08 | 2023-08-10 - 2024-04-17 | Strong Buy |
Inovio Pharmaceuticals IncINO | +196.98% | $35.76 | $106.20 | 2020-01-02 - 2020-12-31 | Strong Buy |
Vectivbio Holding AgVECT | +186.96% | $5.75 | $16.50 | 2022-06-30 - 2023-05-23 | Strong Buy |
Biohaven LtdBHVN | +149.77% | $11.09 | $27.70 | 2022-10-11 - 2023-10-11 | Strong Buy |
Ardelyx IncARDX | +134.30% | $1.72 | $4.03 | 2022-11-16 - 2023-11-16 | Strong Buy |
Christopher Raymond Analyst Color
Get additional color on Christopher Raymond's coverage of popular stocks
6 months ago
DCPH
9 months ago
ABBV
a year ago
BIIB
a year ago
BIIB
a year ago
ABBV
2 years ago
BMRN
Christopher Raymond's Stock Coverage
| Name / Ticker | No. Ratings | Rating | Price Target | Upside/Downside | Action | Date |
|---|---|---|---|---|---|---|
Taysha Gene Therapies IncTSHA | 1 | Strong Buy | $9.00 | +267.35% | Initiates Coverage On | 10 days ago |
Q32 Bio IncQTTB | 1 | Strong Buy | $45.00 | +86.57% | Initiates Coverage On | 17 days ago |
Alx Oncology Holdings IncALXO | 5 | Strong Buy | $21.00 | +30.60% | Maintains | a month ago |
Biomarin Pharmaceutical IncBMRN | 6 | Strong Buy | $107.00 | +18.27% | Maintains | 2 months ago |
Ardelyx IncARDX | 4 | Strong Buy | $15.00 | +129.01% | Maintains | 2 months ago |
Biogen IncBIIB | 8 | Strong Buy | $325.00 | +69.13% | Maintains | 2 months ago |
Allovir IncALVR | 2 | Hold | $1.50 | +98.15% | Downgrades | 4 months ago |
Biohaven LtdBHVN | 3 | Strong Buy | $36.00 | -18.24% | Maintains | 5 months ago |
Karyopharm Therapeutics IncKPTI | 3 | Strong Buy | $5.00 | +262.32% | Maintains | 5 months ago |
Regeneron Pharmaceuticals IncREGN | 3 | Strong Buy | $895.00 | -0.69% | Maintains | 5 months ago |
Deciphera Pharmaceuticals IncDCPH | 1 | Strong Buy | $23.00 | +56.25% | Upgrades | 6 months ago |
Ultragenyx Pharmaceutical IncRARE | 4 | Strong Buy | $130.00 | +194.72% | Maintains | 6 months ago |
Io Biotech IncIOBT | 1 | Strong Buy | $10.00 | +566.67% | Initiates Coverage On | 7 months ago |
Kinnate Biopharma IncKNTE | 2 | Hold | $4.00 | +50.94% | Downgrades | 7 months ago |
Abbvie IncABBV | 7 | Strong Buy | $170.00 | +3.50% | Maintains | 9 months ago |
Cogent Biosciences IncCOGT | 1 | Strong Buy | $22.00 | +236.91% | Maintains | 10 months ago |
Akebia Therapeutics IncAKBA | 2 | Strong Buy | $4.00 | +187.77% | Upgrades | a year ago |
Vectivbio Holding AgVECT | 2 | Hold | $17.00 | +0.89% | Downgrades | a year ago |
Meiragtx Holdings PLCMGTX | 1 | Strong Buy | $25.00 | +376.19% | Maintains | a year ago |
Vertex Pharmaceuticals IncVRTX | 4 | Strong Buy | $385.00 | -2.06% | Assumes | a year ago |
Amgen IncAMGN | 9 | Strong Buy | $288.00 | +9.06% | Maintains | a year ago |
Agios Pharmaceuticals IncAGIO | 1 | Strong Buy | $41.00 | N/A | Initiates Coverage On | a year ago |
Otonomy IncOTIC | 1 | Hold | $0.50 | N/A | Downgrades | 2 years ago |
Biohaven Pharmaceutical Holding Co LtdBHVN1 | 2 | Hold | N/A | N/A | Downgrades | 2 years ago |
Aptinyx IncAPTX | 3 | Hold | $2.00 | N/A | Downgrades | 2 years ago |
Oncorus IncONCR | 2 | Strong Buy | $12.00 | N/A | Maintains | 2 years ago |
Calcimedica IncCALC | 4 | Hold | $2.00 | N/A | Maintains | 2 years ago |
Blueprint Medicines CorpBPMC | 1 | Hold | $65.00 | N/A | Maintains | 2 years ago |
Acceleron Pharma IncXLRN | 2 | Hold | $180.00 | N/A | Downgrades | 3 years ago |
Nuvalent IncNUVL | 1 | Strong Buy | $40.00 | N/A | Initiates Coverage On | 3 years ago |
Solid Biosciences IncSLDB | 1 | Hold | $90.00 | N/A | Initiates Coverage On | 3 years ago |
Aclaris Therapeutics IncACRS | 1 | Strong Buy | $30.00 | N/A | Initiates Coverage On | 3 years ago |
Amag Pharmaceuticals IncAMAG | 2 | Hold | N/A | N/A | Upgrades | 4 years ago |
Aimmune Therapeutics IncAIMT | 1 | Hold | $34.50 | N/A | Downgrades | 4 years ago |
Prevail Therapeutics IncPRVL | 1 | Strong Buy | $20.00 | N/A | Initiates Coverage On | 4 years ago |
Inovio Pharmaceuticals IncINO | 2 | Hold | $96.00 | N/A | Downgrades | 4 years ago |
Alexion Pharmaceuticals IncALXN | 1 | Strong Buy | $170.00 | N/A | Assumes | 6 years ago |
Celgene CorpCELG | 1 | Hold | $133.00 | N/A | Assumes | 6 years ago |
Company
AboutNewsBlogStock Investing FAQPlansPrivacy PolicyTerms of ServiceCancellation & RefundsHelp GuidesContactTwitterYouTubeNewsletterWallStreetZen does not provide financial advice and does not issue recommendations or offers to buy stock or sell any security.
Information is provided 'as-is' and solely for informational purposes and is not advice. WallStreetZen does not bear any responsibility for any losses or damage that may occur as a result of reliance on this data.
Information is provided 'as-is' and solely for informational purposes and is not advice. WallStreetZen does not bear any responsibility for any losses or damage that may occur as a result of reliance on this data.